In this April 1, 2021 segment, Gray discusses the moral, scientific, and commercial arguments for widening clinical trials to include everyone, and he offers ideas on how to reach out to historically underserved populations.
In this segment, thought leader Getz previews his upcoming talk at ACRP’s Virtual Conference in May. “I’m going to talk with a lot of optimism about what the future might hold” for clinical trials, he says in our April 1, 2020 segment. While he celebrates the Covid-catalyst which has spurred adoption of new ideas and technologies, Getz cautions we need to look at the future with “a more real and rational assessment” of what’s around the corner in our industry.
In this March 31, 2021 segment, Elliott and Torgal discuss how improving patient engagement and the diversity of the clinical trial patient population are inextricably linked, and share why they are optimistic industry is turning the corner in both areas.
In this March 18, 2021 segment, Dr. Ramaswamy explains how a patchwork of inconsistent state regulations is creating a “bottleneck” for clinicians in many states. He also discusses how to assess your own current state of compliance and the issue’s impact on clinical trial operations.
In this March 24, 2021 segment, Burns outlines how some sites are using technology to vault ahead of their competitors, and how technology can help make trials more effective and patient-centric.
